To obtain contractor services to support subject matter expertise in conjunction with digital transformation services (DTS), cdrh medical device total product lifecycle (TPLC) and management…
Ended Awarded Last action
- Contract number
- 75F40119F19092
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $458,528
Award facts
- Contract value 30% obligated
-
- $458,527.86 Current, with exercised options
- $1,523,428.50 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$59,072 | |
| Original award | $517,599 |
About this award
This is a Blanket Purchase Agreement (BPA) call award under the General Services Administration (GSA) Professional Services Schedule (PSS) contract, with the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) as the funding agency. The contract is for contractor services to support subject matter expertise in conjunction with digital transformation services (DTS), medical device total product lifecycle (TPLC), and management operations review and modernization (MORM) for the FDA. The potential value of this award to the prime contractor, Brillient Corporation, is $1,523,428.50. Brillient is a minority-owned, for-profit small business that provides a range of professional and technical services to federal agencies.
Description
To obtain contractor services to support subject matter expertise in conjunction with digital transformation services (DTS), cdrh medical device total product lifecycle (TPLC) and management operations review and modernization (MORM) organizational a
Quick answers
Who was awarded contract 75F40119F19092?
75F40119F19092 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on September 7, 2019.
How much is contract 75F40119F19092 worth?
The government has obligated $458,528 on 75F40119F19092. Its potential value, with all options, is $1,523,429.
Is contract 75F40119F19092 an order under another contract?
Yes. 75F40119F19092 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on The Professional Services Schedule (PSS).
Was contract 75F40119F19092 competed?
The extent of competition for 75F40119F19092 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award